SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to increased 2025 revenue guidance driven by strong DefenCath sales and the Melinta portfolio. The community is discussing the raised guidance and potential for further growth, with some expressing excitement about the company's future prospects. Broader discussions include CorMedix's strategic investment in Talphera and potential impacts of upcoming clinical data.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's stock is trending due to a widespread AWS outage impacting numerous services and applications, sparking concerns about the reliability of centralized infrastructure. The community is discussing the extent of the disruption and its potential financial repercussions, while also questioning Amazon's ability to maintain its competitive edge in cloud computing and AI amid the issues.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors are closely watching for potential asset sales and a possible foreign partnership, highlighted by a recent Memorandum of Understanding with a major global steel producer. Community discussions revolve around the impact of this MoU and potential buyout scenarios, alongside the company's strategic position in the US steel market. Additionally, tariffs and macro data surrounding the steel and automotive industries remain key talking points for CLF.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC is trending due to positive Phase 3 trial data for its breast cancer therapy, gedatolisib, showing a significant reduction in disease progression risk, leading to community excitement and analyst upgrades. The community is discussing the potential for FDA approval, buyout scenarios, and the impact on treatment standards, while also noting the possibility of a near-term offering. However, some caution against shorting and potential overvaluation, recognizing the strong positive data, while others suggest a pullback is imminent.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending due to promising data from its PATHFINDER 2 study, highlighting the potential of its Galleri multi-cancer early detection test; the study results pave the way for FDA submission. Community members are discussing the potential for Medicare coverage and revenue growth, especially with support in Congress, and Samsung's commitment to marketing in Asia. The company is also presenting at the Jefferies Global Healthcare Conference on Wednesday.

BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is trending due to a recently announced strategic partnership, sparking excitement among investors. The community is focused on the potential impact of the partnership, especially given the stock's low float and history as a runner. Some traders believe the stock is due for a significant upward move, while others caution about potential dilution and volatility.

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

RAPT Therapeutics Inc

RAPT Therapeutics is trending due to an FDA clearance for a Phase 2b trial of RPT904 in food allergy, sparking bullish sentiment. Community members are discussing the potential for a significant retail squeeze, fueled by positive analyst ratings and price targets. Some are also highlighting the company's cash runway and upcoming data readouts as potential catalysts.

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

NuCana plc - ADR

NuCana plc

NCNA is trending due to encouraging data releases and regulatory approvals regarding their oncology assets, sparking optimism within the community. Bullish investors are actively discussing the potential for significant price appreciation, fueled by the company's compelling early efficacy in chemo-resistant settings. Some traders are drawing comparisons to other low floaters and anticipating a large move, highlighting the upcoming presentation at the ESMO congress.

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals is trending due to H.C. Wainwright's reiterated Buy rating and a price target of $40, sparking community discussion about its potential. The stock is also gaining attention following the presentation of Phase 1/2 data of CRB-701 at ESMO 2025, with community members actively sharing trading plans and insights on key technical levels.

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

Safe Pro Group Inc

SPAI is trending due to a strategic investment of $14 million, with community members pointing to this as a sign of confidence in the company's AI-based drone technology. Bullish sentiment is fueled by potential breakout setups, high trading volume, and the company's expansion in the Asia-Pacific region. Discussions also highlight Safe Pro Group's collaborations and its role in landmine detection using AI, positioning it as a key player in the defense and security sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Weekly Stock Market Update: Apple, Taiwan Semiconductor and Novo Nordisk

It was a volatile but ultimately positive week on Wall Street, marked by renewed tensions in the U.S.-China trade war and a strong start to the earnings season. Major banks exceeded expectations...

Bunge Volunteers Serve Hand in Hand to Advance Food Security on World Food Day 2025

Bunge Global SA (NYSE:BG), a premier agribusiness solutions company connecting farmers to consumers, is expanding its Global Volunteer Program for World Food Day 2025, following its recent...

Top Stocks: Walmart, Bunge Global, and AMD

After a mixed market performance on Tuesday, when major indices slipped at the close despite intraday gains, Wednesday opened on a bullish note.The S&P 500 rose 0.4%, driven by robust earnings...

Bunge shares soar 11% after Trump considers China cooking oil embargo

Bunge Global jumped on the back of the Trump administration's threat to cut off U.S. purchases of Chinese cooking oil...

Bunge Announces Reporting Segment Changes and Recast Outlook

Bunge Global SA (NYSE:BG) today announced that it has changed its segment and volume reporting to align with the Companys value chain operating structure following the completion of Bunge's...

New Strong Sell Stocks for September 17th

BG, AVT and ALSN have been added to the Zacks Rank #5 (Strong Sell) List on September 17, 2025.

The uncertainty around President Donald Trump’s tariffs has reportedly dented U.S. soybean farmers but boosted the prospects for their Brazilian counterparts.A Reuters report, citing soybean traders, <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/china/us-losing-out-china-soybean-sales-brazil-fills-key-supply-period-2025-08-13/">said</a> that Chinese buyers, who are top importers of the oilseed crop, are gravitating toward Brazil amid the tariff standoff.Chinese importers have booked eight million metric tons of Soybean cargoes for September, all from South America, the report said, citing traders.&nbsp;These importers have contracted to buy four million metric tons of soybeans in October, also from South America. This is half the requirement. But the country will likely complete this year’s bookings by early September.Chinese oilseed importers have reportedly procured 7 million tons of soybeans from the U.S. during the first two months of 2024.The report stated that typically, China procures U.S. soybeans between September and January, and then shifts to purchases from Brazil once the harvest begins in South America.According to the report, China imported 105 million metric tons of soybeans in 2024, with 22.13 million tons or roughly 21% coming from the U.S.U.S. Department of Agriculture (USDA) data showed that U.S. soybean exports in 2024 totaled 52.21 million metric tons, valued at $24.47 billion.&nbsp;On Sunday, President Trump called for China to <a href="https://stocktwits.com/news-articles/markets/equity/trump-hopes-china-will-quickly-quadruple-soybean-purchases-from-us/chrunbERd46">“quadruple its soybean orders,</a>" alluring importers by promising “rapid service” if China made the orders.Food processing and commodity trading company <a href="https://stocktwits.com/symbol/ADM">Archer-Daniels-Midland Company’s (ADM) stock</a> was up 0.34% in the early premarket session on Wednesday. Sentiment toward the stock improved to ‘bullish’ (65/100) by early Wednesday from ‘neutral’ a day ago. Sentiment toward Agribusiness and food company <a href="https://stocktwits.com/symbol/BG">Bunge’s (BG)</a> stock stayed ‘bearish’ (37/100).The &nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, the exchange-traded fund (ETF) that tracks the S&amp;P 500 Index, is up 10.31% for the year compared to the 28.5% gain for the <a href="https://stocktwits.com/symbol/EWZ">iShares MSCI Brazil ETF (EWZ)</a>.China has been reducing its reliance on the U.S. for agricultural commodities since Trump took office in 2021 due to the trade war unleashed by the president.This week, the U.S. and China agreed to extend the tariff truce by 90 days, offering a reprieve.The truce may not trigger purchases from the U.S., given that Beijing’s tariffs on U.S. soybean imports stand at 23%, making them uncompetitive. Excluding the tariffs, US soybeans for October shipment would have been cheaper than Brazilian imports by $40 per ton.&nbsp;Chinese importers’ decision to stay away from the U.S. market will likely dent the soybean futures pricing on the Chicago Board of Trade, Reuters said. The futures prices have been on a secular downtrend since mid-2022.Futures pricing for the agricultural commodity climbed for a second straight day on Tuesday after the USDA trimmed its harvest outlook forecast for the 2024/25 period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/figma-reaches-settlement-with-motiff-forcing-rival-to-halt-sales-of-ui-design-tool/chrC2stRdBi">Figma Reaches Settlement With Motiff, Forcing Rival To Halt Sales of Its UI Design Tool — Retail Cheers ‘Solid Win’</a>

An aerial view shows Mark German loading soybeans from grain bins into a truck so they can be hauled to an elevator and sold on August 01, 2025, in Dwight, Illinois. 

US Soybean Exports Hit As Trump’s Tariffs Drive Chinese Oilseed Importers to Brazil, Other South American Countries

The report said that typically, China procures U.S. soybeans between September and January, and then pivots to purchases from Brazil once harvest begins in South America.

Equity

The report said that typically, China procures U.S. soybeans between September and January, and then pivots to purchases from Brazil once harvest begins in South America.


U.S. President Donald Trump said late on Sunday that he hoped China would quadruple its soybean orders from the U.S., which would also help Beijing substantially reduce its trade deficit.“China is worried about its shortage of soybeans. Our great farmers produce the most robust soybeans. I hope China will quickly quadruple its soybean orders,” Trump <a target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115007977998503665">wrote</a> on Truth Social. He also thanked Chinese President Xi Jinping and assured the U.S. would provide “rapid service” if China made the orders.Trump’s comments come days after China’s official data showed that the country’s soybean imports rose to the highest ever for July, as per a <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/markets/asia/chinas-july-imports-soybeans-crude-oil-rise-2025-08-07/">Reuters report</a>, following record imports from Brazil. This was likely fueled by concerns over supplies from the U.S., as the two countries are still negotiating a trade deal.Retail sentiment on Stocktwits about grain trader <a href="https://stocktwits.com/symbol/ADM">ADM</a> was in the ‘bullish’ territory at the time of writing, while users were ‘bearish’ about <a href="https://stocktwits.com/symbol/BG">Bunge</a>.Soybean prices have declined this year, hurt by robust production in Brazil and Argentina, as well as a slump in demand, particularly from top importer China, where inventories had soared at the beginning of the year.Despite the tepid demand at home, Chinese businesses are preparing for the worst-case scenario in the U.S.-China trade negotiations. Brazil's soybean production is projected to increase to 169.3 million tons in 2024/25, with 73% of its exports destined for China.However, the recently concluded talks between China and the U.S. have been positive, with the two sides extending a trade truce for a further three months following the expiration of the earlier agreement on Aug. 12. Trump has even floated the idea of a meeting with President Xi if the two countries strike a trade deal.Chinese purchases of soybeans would likely boost farmer income in several key Midwest states. According to the U.S. Department of Agriculture, soybean crush for the marketing year 2025/26 is forecast at a record high of 2.54 billion bushels, supported by higher domestic use of soybean oil for biofuel production.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/soft-bank-reportedly-selects-banks-for-us-ipo-of-pay-pay/chrumQtRd4t">SoftBank Reportedly Selects Banks For US IPO Of PayPay: Next Big Bet After Arm?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. President Donald Trump takes questions from reporters after signing an executive order in the South Court Auditorium in the Eisenhower Executive Office Building on August 5, 2025 in Washington, DC. 

Trump Hopes China Will ‘Quickly Quadruple’ Soybean Purchases From US, Promises ‘Rapid Service'

Trump’s comments come days after China’s official data showed that the country’s soybean imports rose to the highest ever for July.

BG Q2 Earnings Beat, Revenues Down Y/Y on Weak Results Across Segments

Bunge Global's Q2 profit beats estimates but slides 24% as weak segment results offset gains from lower costs.

Here's What Key Metrics Tell Us About Bunge Global (BG) Q2 Earnings

Although the revenue and EPS for Bunge Global (BG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Bunge Global SA engages in agribusiness including food and ingredients. It operates through the following segments: Agribusiness, Refined & Specialty Oils, Milling, Sugar & Bioenergy, and Corporate & Other. The Agribusiness segment is an integrated, global business principally involved in the purchase, storage, transportation, processing and sale of agricultural commodities and commodity products. The Refined & Specialty Oils segment includes businesses that sell vegetable oils and fats, including cooking oils, shortenings, specialty ingredients, and renewable diesel feedstocks. The Milling segment refers to the businesses that sell wheat flours, bakery mixes, and corn-based products. The Sugar & Bioenergy segment consists of results from the company’s previously owned 50% ownership interest in BP Bunge Bioenergia. The Corporate & Other segment focuses on the salaries and overhead for corporate functions that are not allocated to individual reporting segments because the operating performance of such reporting segments is evaluated. It connects farmers to consumers to deliver essential and sustainable food, feed and fuel. The company was founded on February 14, 2023 and is headquartered in Chesterfield, MO.

Bunge Global SA

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

BG
Bunge Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BG News

BGBunge Ltd.